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Background: In the process of epithelial mesenchymal transition EMT, the disassembly of junctional adhesion
complexes such as E-cadherin is a remarkable sign during changes in cell morphology and polarity. However,
E-cadherin expression is dynamic, and is regulated by the cellular endocytic system; it is also involved in cell
signaling mechanisms. In this study, we investigated the role of E-cadherin in colorectal tumors and the relationship
with recycling endosome protein Rab11 in colon cell transformation.
Methods: For tissue screening, the expressions of E-cadherin and Rab11 in colorectal tumors were identified by
immunohistochemistry in 113 patients with colorectal carcinoma. For the in vitro cell experiment, GFP-tagged
Rab11 plasmid was transfected into HT29 colon cells, E-cadherin expression and cell transformation were
monitored by Western blot and confocal microscopy.
Results: In immunohistochemistry, the mean score of E-cadherin in tumor and normal tissues was 1.41 ± 0.06 and
1.08 ± 0.06 (p < 0.05). The mean score of Rab11 in tumor and normal tissues was 0.51 ± 0.05 and 0.18 ± 0.02
(p < 0.05). Synchronous overexpression of E-cadherin and Rab11 was noted in 74 patients (66.5%) with colorectal
carcinoma. When GFP-tagged Rab11 plasmid was overexpressed in cultured colon cell line HT-29, the E-cadherin
expression was up-regulated, and cell membrane protrusion was induced, which resulted in cell transformation and
cell migration.
Conclusions: This study demonstrated the importance of the overexpression of Rab11 and E-cadherin in colorectal
cancer. The results indicated that Rab11 together with E-cadherin might be potential markers for colorectal cancer
progression and treatment.
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Most tumors are epithelial based cell types. Epithelial
Mesenchymal Transition (EMT) is thought to be a marker
of tumor progression and metastasis. Normal epithelial
cells express cadherin, catenin and other junctional adhe-
sion proteins in the areas of cell-cell contacts; however,
tumor cells that express mesenchymal markers have a
greater tendency to be invasive and metastasize [1].
E-cadhrin has been considered to be a “tumor suppres-
sor” marker, as the breakdown of cell-cell contacts pro-
motes cell transformation and further migration. However,* Correspondence: wtchao@thu.edu.tw
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unless otherwise stated.recent evidence demonstrated a promoting role of high ex-
pression of E-cadherin in aspects of tumor progression. An
unexpected high expression of E-cadherin in tumor pro-
gression was observed in aggressive brain tumor [2] and in
inflammatory breast carcinoma; E-cadherin was identified
as being involved in the pathogenesis of advanced breast
carcinoma [3,4]. It has also been demonstrated in clinical
studies that the E-cadherin and β-catenin mRNA levels
were increased in colon cancer progression and in liver
metastasis [5]. E-cadherin protein expression and locali-
zation have also been found to be increased in primary
colorectal tumors [6]. However, the related biological
meaning and the underlying cellular mechanism are still
under investigation.Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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epithelial cells between EMT and MET, the expression of
E-cadherin is regulated dynamically and does not just act
in the role of tumor suppressor [7]. Recent reports have
also pointed towards an alternative role of E-cadherin in
carcinogenesis, which suggests that it may not just be that
of a “sticky” molecular complex in between cells – the
dysregulated over-expression of E-cadherin may partici-
pate in tumor progression through its associated cellular
mechanisms [8-10]. In epithelial cells, cadherins and cate-
nins form strong cell-cell contacts and are also dependent
on vesicle-mediated intracellular transport. Continual traf-
ficking of E-cadherin to form the cell junction is essential
for morphogenesis [11,12]. Increases of E-cadherin endo-
cytosis and recycling have been shown to be correlated
with cancer progression [13,14].
Vesicles transport mediated through the endocytic sys-
tem including endocytosis and recycling is controlled pri-
marily by small GTPases of the Rab family [15]. Different
Rab proteins are localized in cellular compartments and
regulate distinct vesicles and endosome transport routes.
It has been demonstrated that Rab proteins were associ-
ated with cancer metastasis [16-18]. Rab11 has been
shown to function in recycling endosome movement to
the membrane and regulate epithelial cell polarity [19,20],
and also been demonstrated to be related to hypoxia-
stimulated cell invasion in breast carcinoma [21]. Hence,
dysregulation of the expressions of Rab proteins may be
an important component of human carcinogenesis, and a
recent study also illustrated that Rab11-mediated recycling
endosome is required for E-cadherin trafficking during
epithelial morphogenesis. Active Rab11 can carry E-
cadherin to the cell-cell contacts; however, the Rab11
inactive form fails to regulate recycling endosome for E-
cadherin membrane targeting [22]. Although in vitro stud-
ies have demonstrated that Rab11 can regulate E-cadherin
membrane targeting, its role in cancer cell transformation
is still not clear, and the relationship with the tumor
suppressor role of E-cadherin is still controversial.
Colorectal cancer is one of the major causes of death
worldwide, and the E-cadherin expression dynamics may
be critical in colorectal tumor progression. Thus, we
speculated that Rab11-mediated E-cadherin turnover is
an important mechanism in colorectal tumor formation.
In this study, the expressions of E-cadherin and Rab11
were examined pathologically in colorectal tumor speci-
mens, and Rab11 was also over-expressed in cultured
colon cells for in vitro transformation study.
Methods
Patients and ethics statements
The study group consisted of 113 consecutive patients
(age range, 24–93 years old, median age, 59 years old,
65 male, 48 female) who had undergone resection forlocalized colorectal cancer from April 1997 to December
2003 at Ching-Cheng General Hospital, Taiwan. The
protocol was reviewed and approved by the Ching-Cheng
General Hospital Institutional Review Board (HT110018).
Written informed consent was obtained from all patients.
Archival paraffin-embedded samples were used to build
up tissue microarray blocks in the Department of Medical
Technology of Yuanpei University in 2008. Patients with
inflammatory disease, infection, bowel obstruction or per-
foration were excluded. Tumors were located in the as-
cending colon in 21 patients (19%), transverse colon in 6
patients (5%), descending colon in 5 patients (4%), sigmoid
colon in 26 patients (23%) and rectum in 55 patients
(49%). All primary cancerous tissues were excised.
Under TNM (AJCC, 7th ed.) classification, 11 patients
had stage I disease, 42 patients had stage II disease, 52
patients had stage III disease and 8 patients had stage IV
disease. Colorectal carcinoma specimens and uninvolved
mucosa specimens were obtained during surgery. All
protein expression assessments for this study were
carried out without knowledge of the pathological data.
Cell culture and transfection
HT-29 and SW 480 colon cells (ATCC, VA, USA) were
grown in Dulbecco’s modified Eagle’s Medium (DMEM)
supplemented with 10% calf serum, penicillin and
streptomycin (GIBCO-BRL, Gaithersberg, MD, USA)
and kept in an incubator under 5% CO2 at 37°C. For
transfection, cells were grown on 24-well plates in nor-
mal growth medium without antibiotics, and Lipofecta-
mine 2000 transfection reagent (Invitrogen, CA, USA)
was used for GFP-tagged Rab11 wild-type, dominant
negative (DN) mutant (Addgene, MA, USA) and Rab11
shRNA plasmid (RANi core, Academia Sinica, Taiwan)
transfection. Cells were analyzed 24 hr post-transfection,
and the efficacy of transfection was confirmed by immu-
noblot analysis of cell lysates using a rabbit anti-GFP anti-
body (abcam, MA, USA).
Immunohistochemistry
The tissue specimens were first fixed in 4% paraformal-
dehyde for 2 hrs. After dehydration, specimens were
then embedded in paraffin blocks. 5-μm-thick paraffin
sections were cut and deparaffinized in xylene substitute
and rehydrated in graded alcohols and distilled water.
Antigen retrieval was achieved by heating the samples
without boiling in 0.01 M citrate buffer, pH 6.0, with
0.1% tween 20. This treatment was conducted twice for
10 min. The sections were washed in double distilled
water (ddH2O). The endogenous peroxide was blocked
by 0.3% hydrogen peroxide in methanol for 10 min. The
sections were then incubated with E-cadherin (1:150)
(BD Biosciences, USA) or Rab11 (1:80) antibodies (Cell
signaling technology, MA, USA) at room temperature
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used to reveal the primary antibody; the secondary
antibody (reagent 1B in DAB kit) was incubated with the
sections for 10 min. After washing in ddH2O thrice for
2 min, the sections were then incubated with streptavidin-
peroxidase conjugate (reagent 2 in DAB kit) for 10 min.
After washing, the final staining was performed in diami-
nobenzidine tetrahydrochloride (DAB) solution (reagent
3A-3C in 1 ml ddH2O) for 5 min. The nuclei were coun-
terstained with Mayer’s hematoxylin (reagent 4 in DAB
kit) for 3 min. After washing with ddH2O, the slides were
then transferred through an ascending ethanol series
(95%, 100%) and xylene substitute before mounting. The
scoring used for immunohistochemistry was the “I” index
[6], the equation for which is I = 0*f0 + 1*f1 + 2*f2 + 3*f3,
where f0-f3 are the fractions of the cells showing a defined
level of staining intensity (from 0–3); the numbers 0–3
represent the following: “0” negative, no detectable stain-
ing, “1” weak, but still detectable staining, “2” moderate,
clearly positive but still weak; and “3” heavy and intense
staining.Western blots
Tissue samples were cut into 2-3-mm pieces and homoge-
nized in lysis buffer (1% NP-40, 50 mM Tris pH 7.4,
150 mM NaCl, 2 mM MgCl2, 1 mM EGTA, and protease
and phosphatase inhibitors) using a homogenizer on an ice
tray, and the protein concentration was determined by
BCA reagent. Protein samples were mixed with sample buf-
fer, boiled for 5 min and separated by SDS–PAGE. Proteins
on gel were then transferred onto PVDF membrane,
blocked in blocking buffer containing 5% BSA, and then
probed with primary antibodies against E-cadherin, Rab11,
vimentin ( Epitomics, CA, USA) or GAPDH (Santa Cruz,
CA, USA ), followed by incubation with appropriate HRP-
conjugated secondary antibodies. Blots were developed
using an enhanced chemiluminescence system.Trans-well cell migration assay
HT-29 cells were transfected with GFP-Rab11 or Rab11
shRNA. After 48 hours, cells were trypsinized into trans-
well insert (BD Biosciences) for cell migration assay.
Transfected cells were transferred to the upper chamber
of the trans-well insert that with 8 μm pore size and
containing serum-free medium. Cells were allowed to
migrate for 12 hours toward the bottom chamber which
was filled with normal serum medium. Cells remaining
on the upper membrane were removed by cotton swab.
The migrated cells on the bottom side were fixed and
stained with DAPI nuclear dye. The migrated cells were
then revealed by fluorescence microscope and counted
for quantification.Immunofluorescence microscopy
Cells grown on glass coverslips were fixed with 3.7%
formaldehyde and permeabilized in 0.1% Triton-X 100.
For the transfection experiment, cells were first grown
on cover slips for 24 hrs and then transfected with GFP-
tagged Rab11 wild-type or dominant negative plasmid
for an additional 24 hrs. The fixed cells were incubated
with mouse anti-E-cadherin antibody (1:100 dilution in
PBS/0.1% Triton-100/3% BSA) at room temperature for
1 hr and then incubated with Cy3 conjugated anti-
mouse secondary antibodies (1:200 dilution in PBS/0.1%
Triton-100/3% BSA) at room temperature for 1 hr. Cov-
erslips were mounted with Gel Mount aqueous mount-
ing medium (Sigma, St. Louis, MO, USA). Images were
acquired using a Zeiss LSM 510 META confocal micro-
scope with a 63× objective (1.4 oil). To analyze the cell
morphology changes for transformation, cells were
scanned by a laser confocal microscope with z-sections
for 3D image construction of the side view. The trans-
fected cells chosen for scanning were either localized
inside the cell colony or on the margin of the island.
Statistics
Results are expressed as mean ± standard deviation. Chi-
squared tests were used to compare categorical variables.
The Student t-test was used to compare continuous vari-
ables. Differences at the p <0.05 level were considered
statistically significant. For cell culture experiments, at
least three independent experiments were performed.
Results
Elevated E-cadherin and Rab11 expressions were revealed
in colon tumor tissues
This study first examined the E-cadherin and Rab11 ex-
pression patterns in nine colon carcinoma patients. Tumor
tissue and non-tumor tissue including the distal and prox-
imal ends of colon tissues from the same patient were col-
lected. Tissues were processed for immunohistochemistry
(IHC) with antibodies against E-cadherin and Rab11.
In the IHC results, the mucosa cells of non-tumor tis-
sue, which was indicated to be a normal tissue, exhibited
the basal level expression of E-cadherin in most of the
cell membrane; weak expression of Rab11 was detected
in the epithelial cytoplasm. In colon tumor tissue, ser-
ious proliferation of the cancer cells was observed, and
E-cadherin was found to be intensively expressed in the
cell membrane; the Rab11 expression was also found to
be increased in cancerous cells (Figure 1a). The inten-
sities of E-cadherin and Rab11 expressions in tissues
were scored and quantified using the “I” index as de-
scribed in Methods, and the results showed that the ex-
pressions of E-cadherin and Rab11 in tumor tissues were
significantly higher than in normal tissues in the pre-
liminary 9 cases (Figure 1b). Tissue proteins were also
Figure 1 E-cadherin and Rab11 expressions in colon tumor tissues. (a) Colon tumor tissue and non-tumor (indicated to be normal) tissue
samples from the same patient were processed for immunohistochemistry with antibodies against E-cadherin or Rab11; micrographs were taken
using a Zeiss light microscope. Scale bar = 50 μm. (b) E-cadherin and Rab11 expressions in tissues from 9 patients were quantified by “I” index
scoring as described in Methods. (c) Protein extracts from colon tumor tissue and non-tumor tissue were subjected to SDS-PAGE and Western
blot analysis to determine the expression levels of E-cadherin and Rab11. GAPDH was used as the internal loading control. (d) Quantification of
E-cadherin and Rab11 protein expressions in 9 patients by Western blot assay. Value = mean ± SD, * p < 0.05. (e) Immunohistochemistry study of
colon tumor tissue showed the E-cadherin and Rab11 expressions in colon tumor infiltrated cells. The asterisk indicates the tumor region, arrows
indicate the tumor infiltrated cell nest, and the arrowhead indicates a disarranged gland-like structure. Scale bar = 50 μm. (f) Colorectal tumor and
non-tumor (indicated to be normal) tissue paraffin sections from 113 patients were mounted on glass slides as a tissue microarray. E-cadherin
and Rab11 were detected by immunohistochemistry. The expressions of E-cadherin and Rab11 were scored and quantified by the “I” index as
described in Methods. Value = mean ± SD, * p < 0.05.
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Rab11 expressions. Samples of one of the patients,
demonstrated in Figure 1c, showed that E-cadherin and
Rab11 were both highly expressed in tumor tissue. By
Western blot analysis, the expression levels of E-
cadherin and Rab11 were quantified in the initial 9 pa-
tients (Figure 1d). By immunocytochemistry, infiltrated
tumor nests were also found in the stroma of colon
tumor tissue, and E-cadherin and Rab11 were stained
intensively in these infiltrated tumor cells (Figure 1e).
These data suggested that E-cadherin and Rab11 might
play important roles in colon tumor cell transformationand migration based on pathological evidence. In order
to examine the relationship between E-cadherin and
Rab11 expressions in colorectal tumors with statistical
significance, tissue array chips were created from 113
patients and IHC staining with E-cadherin and Rab11
antibodies was performed. The quantified results showed
that the expressions of E-cadherin and Rab11 (Figure 1f )
were both higher in tumor parts than in non-tumor
parts. The mean scores of E-cadherin in the tumor and
normal mucosa were 1.41 ± 0.06 and 1.08 ± 0.06, respect-
ively, which were significantly different (p < 0.05). In
addition, the mean scores of Rab11 in the tumor and
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were also significantly different between the two groups
(p < 0.05).
In 84 patients (74.3%), the E-cadherin expression was
higher in tumor tissues than in non-tumor tissues. The
specimens of stage IV disease had the largest percentage
of over-expression (87.5% versus 12.5%). The Rab11 ex-
pression was higher in tumor tissues than in non-tumor
tissues in 100 cases (88.5%), especially specimens of
stage III tumors, which showed the largest percentage of
over-expression of Rab11 (94.2% versus 5.8%).
When E-cadherin and Rab11 were combined together
for observation, over-expression of both proteins was
presented in 74 patients (65.5%). Solitary over-expression
of Rab11 was found in 26 patients (23.0%) and solitary
over-expression of E-cadherin was found in 10 patients
(8.9%). Only 3 patients (2.7%) lacked any over-expression
of the two proteins. Furthermore, all of these patients were
classed as stage I or II. However, there was no significant
difference between the stages with different expressions of
E-cadherin or Rab11 (p = 0.09). These results suggested
that the elevation of E-cadherin or Rab11 plays an import-
ant role in colorectal carcinoma formation regardless of
stage (Table 1).Proportional expressions of E-cadherin and Rab11
proteins were associated with epithelium morphology in
cultured HT-29 colon cells
To examine the functions of E-cadherin and Rab11
in vitro, colon cell line HT-29 was used in this study. HT-
29 cells have been demonstrated to be an ideal cell model
for cell differentiation [23]. The phenotype of HT-29 was
first examined and compared with another colon cell line,
SW480. Cells grown on coverslips were fixed, and the E-
cadherin expression was analyzed by immunofluorescent
microscopy. An organized membrane E-cadherin staining
pattern was revealed in HT-29 cells; however, the distribu-
tion of E-cadherin was shown to be diffused in SW480
cells (Figure 2a). The Western blot results showed greater
Rab11 and E-cadherin protein expressions in HT-29 cells
than in SW480 cells (Figure 2b). The results suggested
that the proportional expression levels of junctionalTable 1 E-cadherin and Rab11 expression patterns in 113 col
No. of cas
E-cadherin + Rab11+ E-cadherin - Rab
Stage I 9/11(81.82%) 1/11(9.09%)
Stage II 23/42 (54.76%) 13/42 (30.95%
Stage III 38/52 (73.08%) 11/52 (21.15%
Stage IV 4/8 (50.00%) 1/8 (12.50%
Total patients 74/113 (65.49%) 26/113 (23.01
The symbols (+) and (−) indicate the expression level according to tissue scoring inadhesion protein E-cadherin and recycling endosome
protein Rab11 are associated with colon cell morphology.
Rab11 overexpression in colon cells up-regulated
E-cadherin expression and induced membrane
protrusion and cell migration
In order to determine the effects of Rab11 in colon cell
morphogenesis, GFP-tagged Rab11 plasmid was overex-
pressed in HT-29 colon cells. Western blot results showed
that the E-cadherin expression was up-regulated in Rab11-
overexpressing cells (Figure 3a, b). Rab11 overexpression
also promoted cell migration significantly (Figure 3c, p <
0.01). When cells were treated with shRNA that targets
Rab11, the depletion of Rab11 expression suppressed E-
cadherin expression (3d, 3e), and inhibited cell migration
(Figure 3f, p < 0.001). HT-29 cells transfected with GFP-
tagged wild-type Rab11 plasmid were stained with E-
cadherin antibody and analyzed by immunofluorescent
microscopy. The results showed that GFP-Rab11 was dis-
tributed in the cell leading edge and had induced the cell
membrane protrusion. When the Rab11-overexpressing
cell was localized at the margins of the cell colony and
started to migrate out of the colony, the expression of E-
cadherin in the cell membrane was shown to be decreased
(Figure 3g). When the GFP-Rab11-overexpressing cell was
migrating towards the center of the cell colony, the trans-
fected cells still showed Rab11-induced membrane protru-
sion; however, E-cadherin was stained intensively in the
cell-cell contacts (Figure 3h). These results demonstrated
that the overexpression of Rab11 induced HT-29 mem-
brane protrusion and resulted in two distinct E-cadherin
expression patterns depending on the location of the cells:
E-cadherin was down-regulated when the cell was migrat-
ing out of the cell colony, but E-cadherin was strengthened
on the cell membrane when the cell was migrating in the
cell colony between neighbor cells.
Rab11 induced colon cell transformation
HT-29 cells transfected with Rab11 as shown in Figure 3f
were further analyzed by a confocal microscope with z-
sections. A 3D image was composed from the z-section
images. The side view image showed that the Rab11 over-
expressed cells (Figure 4a) induced cell transformation,orectal carcinoma patients
es, (%)
11 + E-cadherin + Rab11- E-cadherin - Rab11 -
0/11(0%) 1/11(9.09%)
) 4/42 (9.52%) 2/42 (4.76%)
) 3/52 (5.77%) 0/52 (0%)
) 3/8 (37.50%) 0/8 (0%)
%) 10/113 (8.85%) 3/113 (2.65%)
the tumor part being higher or lower as compared with normal tissue.
Figure 2 Rab11 and E-cadherin expressions in cultured colon cells. (a) HT-29 and SW480 colon cells were grown on coverslips, cells were
fixed and stained with E-cadherin antibody, and E-cadherin was then revealed by Cy2-conjugated secondary antibody and observed by confocal
microscopy. (b) HT-29 and SW480 cell lysates were collected and subjected to SDS-page. E-cadherin and Rab11 were detected by Western blot,
and GAPDH was used as the internal loading control.
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migrated beneath a neighbor cell (see 3D side view). How-
ever, when cells were transfected with GFP-tagged domin-
ant negative (DN) Rab11, the GFP-Rab11 DN was evenly
distributed in the cytosol and did not induce cell trans-
formation and migration (Figure 4b). This result indicated
that overexpression of Rab11 induced HT-29 cell trans-
formation, which was dependent on Rab11 activity.Discussion
E-cadherin, which functions as an adhesion junction, has
been demonstrated to be an important marker in cancer
biology, as disassembly of E-cadherin is required for
epithelial cell transformation and migration. E-cadherin is
bound with most of the β-catenin located at the cytosolic
side and also interacts with the actin cytoskeleton. β-
catenin is the key component of the Wnt pathway that
can be stimulated for cell growth and proliferation [10]. E-
cadherin has also been shown to regulate initial cell-cell
contacts formation and can further recruit exocyst com-
ponents to the contacts for the formation of cell surface
polarity [24]. Recently, the dark side of E-cadherin has
been revealed gradually in pathological study of differ-
ent cancers. The increased expression of E-cadherin was
found to be associated with the formation of epithelium
tumors. E-cadherin may play an important role in “collect-
ive cell migration” [25] and provide the “anchorage-
independent” property of cancer cells [9]. In our study,
significant over-expression of E-cadherin was found in
colorectal cancer tissues. These findings are consistent
with the previous study of Truant et al. [5], who demon-
strated that the expression ratio of E-cadherin in reference
to the normal adjacent tissue was increased in 57% of
primary tumors. In contrast, only 30% of specimens were
decreased in terms of the expression of E-cadherin in
colorectal carcinoma. Regarding liver metastasis, a signifi-
cantly higher expression of E-cadherin was found at stage
I ~ II than at stage III ~ IV [6]. Therefore, the authors of
the study suggested that the role of high expression ofE-cadherin in colorectal cancer cells may be protective
against widespread metastasis.
As Rab11, which functions as a recycling endosome, has
been reported to play a role in regulating E-cadherin turn-
over in vitro, dysregulation may be associated with cancer
formation. Our data subsequently demonstrated that the
expression of Rab11 was also increased in colorectal can-
cer tissues. Co-overexpression of E-cadherin and Rab11
was found in 65.5% (74/113) of colorectal carcinomas,
which suggests that dysregulation of both molecules might
be associated with the occurrence and progression of colo-
rectal carcinoma. The correlations of expressions of E-
cadherin and Rab11 with stages of colorectal carcinoma
were not statistically significant. However, the number of
E-cadherin and Rab11 co-expressing cases was decreased
in advanced stage cancers (81.8% in stage I, but 50% in
stage IV). As we know, pathological progression from
early adenomatous proliferation through adenomatous
polyp, high grade dysplasia and ultimately, invasive colo-
rectal carcinoma to metastasis occurs as a continuum.
This progression coincides with the accumulation of mul-
tiple genetic alterations during neoplastic progression as
originally described by Fearon and Volgelstein [26]. The
regulatory alteration of E-cadherin and Rab11 may vary
dynamically in the multistep model of progression of
colorectal carcinoma in different stages.
E-cadherin may participate in tumor progression
through its associated cellular mechanisms. In epithelial
cells, β-catenin acts as a linker between transmembrane
E-cadherin and cytosolic actin fibers and forms a junc-
tional adhesion complex. β-catenin is either stable con-
nected to E-cadherin or translocated into the nucleus and
binds to Lef/Tcf transcription factor upon stimulation for
cell proliferation. Free cytosol β-catenin is degraded
through ubiquitin-mediated degradation. Therefore, dy-
namic regulation of membrane E-cadherin and Rab11
may be necessary for cell proliferation and tumor growth.
Rab11 was suggested to play a role in E-cadherin recycling
and enhance membrane E-cadherin dynamics, which may
be involved in cell signaling for cancer cell growth.
Figure 3 Rab11 overexpression induced E-cadherin expression and cell migration in HT-29 cells. HT-29 cells were transfected with GFP-
tagged Rab11 plasmid (a-c) or plasmid constructed with Rab11 shRNA (d-f). After 24 hr, cell lysates were collected and subjected to Western blot
analysis for GFP-Rab11, E-cadherin and Rab11 expressions using anti-GFP, anti-E-cadherin and anti-Rab11 antibodies, respectively. GAPDH was
used as the internal loading control. Quantifications of E-cadherin expression in GFP-Rab11 overexpressed cells (b) and in Rab11 knockdown cells
(e) are shown from at least three independent experiments. Value = mean ± SD, * p < 0.05. Trans-well migration assay for Rab11 overexpression
(c) and knockdown cells (f) were quantified. Value =mean ± SD were from three independent experiments, ** p < 0.01; *** p < 0.001. HT-29 cells
grown on glass coverslips were transfected with GFP-Rab11; cells were then fixed and stained with anti-E-cadherin antibody, followed by staining
with Cy3 conjugated secondary antibody. (g) GFP-Rab11-overexpressing cell migration out of the cell colony or (h) migration towards the center
of the cell colony was observed by confocal microscopy. Arrowheads indicate cell membrane protrusion.
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overexpressed in HT-29 cells induced cell transform-
ation and migration. Intense staining of E-cadherin and
Rab11 were also observed in infiltrated tumor nest cells.
Actin dynamics are required for cell motility, and it has
also been demonstrated that Rab11 interacts with RTK
down-stream target Rac1 and controls moesin activity to
regulate the endocytic cycle and actin cytoskeleton incell migration and collective cell migration [27-29]. Rac1
has been shown to regulate actin nucleation via neural
WASP (N-WASP) and the down-stream Arp2/3 com-
plex [30]. A recent study has also shown that Rac1 acti-
vation is involved in twist1-induced cell transformation
and migration [31]. Taken together, Rab11 plays a role
not just in E-cadherin turnover but also improves the
cytoskeleton reorganization for cell migration.
Figure 4 Rab11 overexpression promoted cell transformation.
(a) GFP-Rab11 wild type and (b) GFP-Rab11 dominant negative
over-expressing HT-29 cells were stained with E-cadherin antibody
and analyzed by a confocal microscope as described in Figure 3h.
The Z-section scanning images in positions A and B (as indicated in
the diagram above) are shown, and Z-stacked images were
composed for a 3D side view.
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however, the formation of cancer is multi-stepped, and
specific protein expressions are restricted and responsible
for different steps of EMT. Cell migration is an integrated
process that requires continuous, coordinated formation
and disassembly of adhesions. These processes are com-
plex and require regulated interaction of numerous tran-
scription factors such as snail/slug or twist, and activation
of specific signaling pathways [32-35]. In this study, the ex-
pression of Rab11 was shown to be associated with cancer
formation, and the expression of Rab11 also induced cell
transformation, which is associated with cell motility.Moreover, Rab 11 could upregulate the expression of E-
cadherin. Thus, Rab11 may be a useful maker together
with E-cadherin for the diagnosis of colorectal cancer pro-
gression. However, the roles of other transcription factors
in this mechanism have not been elucidated and require
further investigation.
In the report of Anastasiadis et al. [9], several possible
mechanisms were suggested to explain the positive role of
E-cadherin in tumor progression. First, E-cadherin may
cross-talk with EGFR signaling. Second, increased E-
cadherin expression may up-regulate the expression of
anti-apoptotic proteins, such as Bcl-2 and Bcl-xL. Third,
E-cadherin may trigger the activation of the PI3K/AKT
pathway through p85. In addition, extracellular N-terminal
E-cadherin ectodomain “shedding” could be a role in
tumor-promoting activities [9]. Our results showing that
Rab11 up-regulated E-cadherin to induce the transform-
ation of cancer cells might be another mechanism of
alteration of neoplastic progression by E-cadherin.
Conclusions
Our data for the first time demonstrated that Rab11 regu-
lated E-cadherin expression and promoted colon cancer
cell transformation. Overexpression of both E-cadherin
and Rab11 was also detected in the majority of colorectal
carcinoma samples. Regulation of the dual protein motifs
might facilitate targeting of the progression of colorectal
carcinoma in the future.
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